Literature DB >> 26365872

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

Habib Rahbar1, Sana Parsian2, Diana L Lam2, Brian N Dontchos2, Nicole K Andeen3, Mara H Rendi3, Constance D Lehman2, Savannah C Partridge2.   

Abstract

OBJECTIVE: The objective was to explore whether 3-T magnetic resonance imaging (MRI) can identify low-risk ductal carcinoma in situ (DCIS).
METHODS: Dynamic contrast-enhanced and diffusion-weighted (DWI) MRI features of 36 DCIS lesions [8 low risk, Van Nuys Pathologic Classification (VNPC) 1; 28 high risk, VNPC 2/3] were reviewed. An MRI model that best identified low-risk DCIS was determined using multivariate logistic regression.
RESULTS: Low-risk DCIS exhibited different DWI properties [i.e., higher contrast-to-noise ratio (P=.02) and lower normalized apparent diffusion coefficients (P=.04)] than high-risk DCIS. A model combining these DWI features provided best performance (area under receiver operating characteristic curve =0.86).
CONCLUSIONS: DWI may help identify DCIS lesions requiring less therapy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Diffusion-weighted imaging; Ductal carcinoma in situ; MRI

Mesh:

Substances:

Year:  2015        PMID: 26365872      PMCID: PMC4688163          DOI: 10.1016/j.clinimag.2015.07.026

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  19 in total

1.  Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: the search continues.

Authors:  Lawrence J Solin
Journal:  J Clin Oncol       Date:  2012-01-17       Impact factor: 44.544

2.  Quantitative diffusion imaging in breast cancer: a clinical prospective study.

Authors:  Erika Rubesova; Anne-Sophie Grell; Viviane De Maertelaer; Thierry Metens; Shih-Li Chao; Marc Lemort
Journal:  J Magn Reson Imaging       Date:  2006-08       Impact factor: 4.813

3.  MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.

Authors:  Christiane K Kuhl; Simone Schrading; Heribert B Bieling; Eva Wardelmann; Claudia C Leutner; Roy Koenig; Walther Kuhn; Hans H Schild
Journal:  Lancet       Date:  2007-08-11       Impact factor: 79.321

4.  Prognostic classification of breast ductal carcinoma-in-situ.

Authors:  M J Silverstein; D N Poller; J R Waisman; W J Colburn; A Barth; E D Gierson; B Lewinsky; P Gamagami; D J Slamon
Journal:  Lancet       Date:  1995-05-06       Impact factor: 79.321

5.  Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant.

Authors:  Gang Chen; Sune Nørhøj Jespersen; Michael Pedersen; Qi Pang; Michael R Horsman; Hans Stødkilde-Jørgensen
Journal:  Magn Reson Imaging       Date:  2005-06       Impact factor: 2.546

6.  In situ duct carcinoma of the breast: clinical and histopathologic factors and association with recurrent carcinoma.

Authors:  N A Miller; J A Chapman; E B Fish; M A Link; E Fishell; B Wright; H L Lickley; D R McCready; W M Hanna
Journal:  Breast J       Date:  2001 Sep-Oct       Impact factor: 2.431

7.  In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.

Authors:  Habib Rahbar; Savannah C Partridge; Wendy B Demartini; Robert L Gutierrez; Kimberly H Allison; Sue Peacock; Constance D Lehman
Journal:  Radiology       Date:  2012-05       Impact factor: 11.105

8.  High-resolution diffusion-weighted imaging for the separation of benign from malignant BI-RADS 4/5 lesions found on breast MRI at 3T.

Authors:  Dorota J Wisner; Nathan Rogers; Vibhas S Deshpande; David N Newitt; Gerhard A Laub; David A Porter; John Kornak; Bonnie N Joe; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2013-11-08       Impact factor: 4.813

9.  Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.

Authors:  Sanaz A Jansen; Gillian M Newstead; Hiroyuki Abe; Akiko Shimauchi; Robert A Schmidt; Gregory S Karczmar
Journal:  Radiology       Date:  2007-12       Impact factor: 11.105

10.  A prognostic index for ductal carcinoma in situ of the breast.

Authors:  M J Silverstein; M D Lagios; P H Craig; J R Waisman; B S Lewinsky; W J Colburn; D N Poller
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

View more
  7 in total

Review 1.  How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?

Authors:  Habib Rahbar; Elizabeth S McDonald; Janie M Lee; Savannah C Partridge; Christoph I Lee
Journal:  Acad Radiol       Date:  2016-03-23       Impact factor: 3.173

Review 2.  Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.

Authors:  Nita Amornsiripanitch; Diana L Lam; Habib Rahbar
Journal:  Semin Roentgenol       Date:  2018-08-30       Impact factor: 0.800

Review 3.  Ductal Carcinoma in Situ: State-of-the-Art Review.

Authors:  Lars J Grimm; Habib Rahbar; Monica Abdelmalak; Allison H Hall; Marc D Ryser
Journal:  Radiology       Date:  2021-12-21       Impact factor: 11.105

4.  Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.

Authors:  Jin You Kim; Jin Joo Kim; Ji Won Lee; Nam Kyung Lee; Geewon Lee; Taewoo Kang; Heesung Park; Yo Han Son; Robert Grimm
Journal:  Eur Radiol       Date:  2018-08-02       Impact factor: 5.315

5.  Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?

Authors:  Lucía Graña-López; Michel Herranz; Inés Domínguez-Prado; Sonia Argibay; Ángeles Villares; Manuel Vázquez-Caruncho
Journal:  Eur Radiol       Date:  2019-08-02       Impact factor: 5.315

Review 6.  The potential of predictive and prognostic breast MRI (P2-bMRI).

Authors:  Francesco Sardanelli; Pascal A T Baltzer; Matthias Dietzel; Rubina Manuela Trimboli; Moreno Zanardo; Rüdiger Schultz-Wendtland; Michael Uder; Paola Clauser
Journal:  Eur Radiol Exp       Date:  2022-08-22

7.  Comparison of the Magnetic Resonance Imaging Findings of Paget's Disease of the Breast and Malignant Tumor Invasion of the Nipple-Areola Complex.

Authors:  Almila Coşkun Bilge; Hale Aydın; Işıl Esen Bostancı; Özge Tanişman; Diba Saygılı Öz
Journal:  Eur J Breast Health       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.